Mr. Pasternak brings decades of global pharmaceutical leadership experience Transition further highlights transformation of ...
"Laurie has extensive experience leading the finance function of high-growth, high-impact companies, and we are thrilled to ...
Hosted on MSN3d
'I know how defeats are taken around home' - Errigal Ciaran is a family affair for McGinleysUse precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
In my opinion ... and Amgen. This is how it will end. But this is not in the interest of big pharma holding biosimilars in the US. Their views do not concord with what biosimilars are supposed to ...
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced the appointment of Andy Pasternak as Chairman of ...
We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...
We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a ...
THOUSAND OAKS, Calif., Jan. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2025 J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Monday, January ...
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $310.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback